Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver A Kent

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|August 23, 2008
Functional integration of microRNAs into oncogenic and tumor suppressor pathwaysCraig D Lotterman, Oliver A Kent, Joshua T Mendell
Molecular and Cellular Biology|December 17, 2004
Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathwayOliver A Kent, Dustin B Ritchie, Andrew M Macmillan
Nucleic Acids Research|May 31, 2014
Lessons from miR-143/145: the importance of cell-type localization of miRNAsOliver A Kent, Matthew N McCall, Toby C Cornish, et al.
The Journal of Biological Chemistry|September 25, 2003
Structuring of the 3' splice site by U2AF65Oliver A Kent, Ayube Reayi, Louise Foong, et al.
Oncotarget|November 12, 2016
An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancerOliver A Kent, María-José Sandí, Helen E Burston, et al.
Molecular Cancer Therapeutics|May 31, 2011
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in miceDipankar Pramanik, Nathaniel R Campbell, Collins Karikari, et al.
BMC Medical Genomics|November 4, 2011
MicroRNA profiling of diverse endothelial cell typesMatthew N McCall, Oliver A Kent, Jianshi Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 28, 2025
Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biologyFabien Binamé, Kevin Leguay, Caroline Spenlé, et al.
The Journal of Clinical Investigation|March 14, 2017
RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146Yoshinori Matsumoto, Jose Larose, Oliver A Kent, et al.
Molecular Biosystems|June 15, 2010
Identifying targets of miR-143 using a SILAC-based proteomic approachYi Yang, Raghothama Chaerkady, Kumaran Kandasamy, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|August 23, 2008
Functional integration of microRNAs into oncogenic and tumor suppressor pathwaysCraig D Lotterman, Oliver A Kent, Joshua T Mendell
Molecular and Cellular Biology|December 17, 2004
Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathwayOliver A Kent, Dustin B Ritchie, Andrew M Macmillan
Nucleic Acids Research|May 31, 2014
Lessons from miR-143/145: the importance of cell-type localization of miRNAsOliver A Kent, Matthew N McCall, Toby C Cornish, et al.
The Journal of Biological Chemistry|September 25, 2003
Structuring of the 3' splice site by U2AF65Oliver A Kent, Ayube Reayi, Louise Foong, et al.
Oncotarget|November 12, 2016
An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancerOliver A Kent, María-José Sandí, Helen E Burston, et al.
Molecular Cancer Therapeutics|May 31, 2011
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in miceDipankar Pramanik, Nathaniel R Campbell, Collins Karikari, et al.
BMC Medical Genomics|November 4, 2011
MicroRNA profiling of diverse endothelial cell typesMatthew N McCall, Oliver A Kent, Jianshi Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 28, 2025
Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biologyFabien Binamé, Kevin Leguay, Caroline Spenlé, et al.
The Journal of Clinical Investigation|March 14, 2017
RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146Yoshinori Matsumoto, Jose Larose, Oliver A Kent, et al.
Molecular Biosystems|June 15, 2010
Identifying targets of miR-143 using a SILAC-based proteomic approachYi Yang, Raghothama Chaerkady, Kumaran Kandasamy, et al.
Pageof 4